ELEKTA SIGNS COOPERATIVE AGREEMENT WITH SWEDISH EXPORT CREDIT CORPORATION

ELEKTA SIGNS COOPERATIVE AGREEMENT WITH SWEDISH EXPORT CREDIT CORPORATION

Stockholm, June 15, 2009

The medical technology company Elekta has entered a cooperative agreement with
SEK, the Swedish Export Credit Corporation. The agreement entails customer
financing and applies globally with the exception of North America, where Elekta
already has an established partner for customer financing.

The cooperative agreement with SEK Customer Financing strengthens and expands
Elekta's opportunities for offering competitive solutions for customer
financing. Within the framework of the agreement, SEK will offer care providers
around the world financing in the form of installment credit and leasing of
Elekta's clinical systems.

Elekta will be able to offer customers financing with limited impact on its own
balance sheet.

“Since the credit crisis began, we have seen increased demand for alternative
financing solutions. I am therefore delighted that we are now able to offer our
customers a broad range of attractive solutions in this area,” says Håkan
Bergström, CFO at Elekta.

“We are pleased to be entrusted with assisting Elekta with its customer
financing platform. This agreement is completely in line with our ambition to
increase the competitiveness of Swedish export companies in the global market,”
says Peter Yngwe, President of SEK.


******
For further information, please contact:

Håkan Bergström, CFO, Elekta AB
Tel: +46 8 587 25 520, e-mail: hakan.bergstrom@elekta.com 

Stina Thorman, Investor Relations, Elekta AB
Tel: +46 8 587 25 437, e-mail: stina.thorman@elekta.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated state of the art tools and treatment planning systems for
radiation therapy and radiosurgery, as well as workflow enhancing software
systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare providers
and patients, Elekta aims to improve, prolong and even save patient lives,
making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000
hospitals globally, and every day more than 100,000 patients receive diagnosis,
treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is
located in Stockholm, Sweden, and the company is listed on the Nordic Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com.